Stockscreener 앱 받기
15.85
11.15%
1.59
시간 외 거래:
15.46
-0.39
-2.46%
전일 마감가:
$14.26
열려 있는:
$14.29
하루 거래량:
52,490
Relative Volume:
1.24
시가총액:
$93.65M
수익:
-
순이익/손실:
$-71.07M
주가수익비율:
-32.35
EPS:
-0.49
순현금흐름:
$-63.98M
1주 성능:
+27.21%
1개월 성능:
+14.36%
6개월 성능:
+92.82%
1년 성능:
+24.28%
1일 변동 폭
$14.25
$16.38
1주일 범위
$12.35
$16.38
52주 변동 폭
$4.2701
$19.00
바이케리어스 서지컬 Stock (RBOT) Company Profile
명칭
Vicarious Surgical Inc
전화
(617) 868-1700
주소
78 FOURTH AVENUE, WALTHAM
RBOT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
15.85 | 93.65M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
바이케리어스 서지컬 Stock (RBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 개시 | Credit Suisse | Outperform |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-11-05 | 개시 | Canaccord Genuity | Buy |
| 2021-10-18 | 개시 | BTIG Research | Buy |
| 2021-10-07 | 개시 | Piper Sandler | Overweight |
모두보기
바이케리어스 서지컬 주식(RBOT)의 최신 뉴스
How the (RBOT) price action is used to our Advantage - Stock Traders Daily
Vicarious Surgical (NYSE:RBOT) Trading Up 9.7%What's Next? - MarketBeat
Objective long/short (RBOT) Report - Stock Traders Daily
How does Vicarious Surgical plan to Revolutionize Robotic Surgery🍩 Conheça a SV Bet! - Oficjalny Portal Gminy Brzesko
Vicarious Surgical CEO Discusses Novel Approach to Surgical Robotics🥎 Conheça a Real Pilar! - Oficjalny Portal Gminy Brzesko
Vicarious Surgical Inc (NYSE:RBOT) Sees Large Growth in Short Interest - MarketBeat
Vicarious Surgical CFO William Kelly stepping down in January - MedTech Dive
Vicarious Surgical’s CFO William Kelly to Depart in 2025 - MPO-mag
Vicarious Surgical CFO moves on - Medical Buyer
Vicarious Surgical CFO William Kelly to Depart - citybiz
Vicarious Surgical Announces CFO William Kelly’s Resignation - TipRanks
Vicarious Surgical CFO to Step Down - MarketWatch
Vicarious Surgical Announces Departure of Chief Financial Officer - The Bakersfield Californian
Vicarious Surgical Inc. Announces Departure of William Kelly as Chief Financial Officer, Effective January 2, 2025 - Marketscreener.com
Vicarious Surgical (NYSE:RBOT) Trading Down 9%Here's Why - MarketBeat
Vicarious surgical CTO Khalifa Sammy sells stock for $3,216 By Investing.com - Investing.com Australia
Vicarious Surgical COO Mazzola sells $3,047 in stock By Investing.com - Investing.com Australia
Vicarious Surgical CEO sells $6,251 in stock to cover tax obligations - Investing.com Nigeria
Vicarious Surgical CFO sells $2,923 in stock By Investing.com - Investing.com Canada
Vicarious surgical CTO Khalifa Sammy sells stock for $3,216 - Investing.com
We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate - Simply Wall St
Vicarious Surgical CFO sells shares worth $976 - Investing.com India
Vicarious Surgical CEO Adam Sachs sells $7,327 in stock to cover taxes - Investing.com Nigeria
Vicarious surgical CTO Khalifa Sammy sells shares worth $5,855 By Investing.com - Investing.com Australia
Vicarious surgical CTO Khalifa Sammy sells shares worth $5,855 - Investing.com
Vicarious Surgical CFO sells shares worth $976 By Investing.com - Investing.com UK
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely - Yahoo Finance
How To Trade (RBOT) - Stock Traders Daily
Vicarious Surgical says first surgical robot trials remain on track, analysts remain neutral - Mass Device
Earnings call: Vicarious Surgical reports narrowed Q3 loss, progress on tech - Investing.com
Vicarious Surgical stock target cut, keeps neutral rating on Q3 loss - Investing.com
Vicarious Surgical price target lowered to $10.50 from $12 at Piper Sandler - TipRanks
Vicarious Surgical Inc. (NYSE:RBOT) Q3 2024 Earnings Call Transcript - Insider Monkey
Vicarious Surgical operating expenses decrease 17% in Q3 2024 - Medical Buyer
Vicarious Surgical Inc. Reports Q3 2024 Financial Results - TipRanks
Vicarious Surgical (RBOT) to Release Quarterly Earnings on Tuesday - Defense World
(RBOT) Proactive Strategies - Stock Traders Daily
Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada
Where are the Opportunities in (RBOT) - Stock Traders Daily
Vicarious Surgical CTO sells shares worth $644 to cover tax obligations - Investing.com India
Vicarious Surgical CEO sells shares worth $802 to cover tax obligations By Investing.com - Investing.com South Africa
Vicarious Surgical CFO sells shares to cover tax obligations - Investing.com
Vicarious Surgical CTO sells shares worth $644 to cover tax obligations By Investing.com - Investing.com South Africa
Vicarious Surgical CFO sells shares to cover tax obligations By Investing.com - Investing.com South Africa
Vicarious Surgical CEO sells shares worth $802 to cover tax obligations - Investing.com India
(RBOT) Trading Report - Stock Traders Daily
Vicarious Surgical CTO sells shares for tax obligations - Investing.com
Vicarious Surgical COO sells shares worth over $1,100 - Investing.com
Vicarious Surgical CEO sells shares worth over $2,300 - Investing.com India
바이케리어스 서지컬 (RBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.57%
자본화:
|
볼륨(24시간):